These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 26460735)

  • 21. Upgrading the Repertoire of miRNAs in Gastric Adenocarcinoma to Provide a New Resource for Biomarker Discovery.
    Pewarchuk ME; Barros-Filho MC; Minatel BC; Cohn DE; Guisier F; Sage AP; Marshall EA; Stewart GL; Rock LD; Garnis C; Lam WL
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
    Li H; Liu JW; Liu S; Yuan Y; Sun LP
    Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatic Analysis of Potential microRNAs in Ischemic Stroke.
    He W; Chen S; Chen X; Li S; Chen W
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1753-1759. PubMed ID: 27151415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression.
    Xie J; Chen M; Zhou J; Mo MS; Zhu LH; Liu YP; Gui QJ; Zhang L; Li GQ
    Oncol Rep; 2014 Apr; 31(4):1715-22. PubMed ID: 24573489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiling and Characterization of microRNAs Responding to Sodium Butyrate Treatment in Gastric Cancer Cells.
    Sun G; Duan H; Meng J; Zhang D
    Comb Chem High Throughput Screen; 2022; 25(11):1875-1888. PubMed ID: 34711158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and validation of potential biomarkers for the detection of dysregulated microRNA by qPCR in patients with colorectal adenocarcinoma.
    Wu X; Xu X; Li S; Wu S; Chen R; Jiang Q; Liu H; Sun Y; Li Y; Xu Y
    PLoS One; 2015; 10(3):e0120024. PubMed ID: 25803870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel microRNA signature predicts survival in stomach adenocarcinoma.
    Ding B; Gao X; Li H; Liu L; Hao X
    Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Early-Onset Preeclampsia-Related Genes and MicroRNAs by Bioinformatics Approaches.
    Song J; Li Y; An RF
    Reprod Sci; 2015 Aug; 22(8):954-63. PubMed ID: 25717061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiRSEA: Discovering the pathways regulated by dysfunctional MicroRNAs.
    Han J; Liu S; Zhang Y; Xu Y; Jiang Y; Zhang C; Li C; Li X
    Oncotarget; 2016 Aug; 7(34):55012-55025. PubMed ID: 27474169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical significance of miR-335, miR-124, miR-218 and miR-484 downregulation in gastric cancer.
    Zare A; Ahadi A; Larki P; Omrani MD; Zali MR; Alamdari NM; Ghaedi H
    Mol Biol Rep; 2018 Dec; 45(6):1587-1595. PubMed ID: 30171475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential microRNA expression in signet-ring cell carcinoma compared with tubular adenocarcinoma of human gastric cancer.
    Li FQ; Xu B; Wu YJ; Yang ZL; Qian JJ
    Genet Mol Res; 2015 Jan; 14(1):739-47. PubMed ID: 25730011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis.
    Fassan M; Pizzi M; Realdon S; Balistreri M; Guzzardo V; Zagonel V; Castoro C; Mastracci L; Farinati F; Nitti D; Zaninotto G; Rugge M
    Hum Pathol; 2013 Sep; 44(9):1804-10. PubMed ID: 23618359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer.
    Zou J; Yin F; Wang Q; Zhang W; Li L
    Int J Clin Exp Pathol; 2015; 8(6):6847-58. PubMed ID: 26261572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated analysis of the miRNA, gene and pathway regulatory network in gastric cancer.
    Zhang H; Qu Y; Duan J; Deng T; Liu R; Zhang L; Bai M; Li J; Zhou L; Ning T; Li H; Ge S; Li H; Ying G; Huang D; Ba Y
    Oncol Rep; 2016 Feb; 35(2):1135-46. PubMed ID: 26719093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiRNA as potential biomarkers and therapeutic targets for gastric cancer.
    Shin VY; Chu KM
    World J Gastroenterol; 2014 Aug; 20(30):10432-9. PubMed ID: 25132759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Value of MiR-383, an Intronic MiRNA, as a Diagnostic and Prognostic Biomarker in Intestinal-Type Gastric Cancer.
    Azarbarzin S; Feizi MAH; Safaralizadeh R; Kazemzadeh M; Fateh A
    Biochem Genet; 2017 Jun; 55(3):244-252. PubMed ID: 28243881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-30-HNF4γ and miR-194-NR2F2 regulatory networks contribute to the upregulation of metaplasia markers in the stomach.
    Sousa JF; Nam KT; Petersen CP; Lee HJ; Yang HK; Kim WH; Goldenring JR
    Gut; 2016 Jun; 65(6):914-24. PubMed ID: 25800782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a novel miRNA-target gene regulatory network in osteosarcoma by integrating transcriptome analysis.
    He C; Gao H; Fan X; Wang M; Liu W; Huang W; Yang Y
    Int J Clin Exp Pathol; 2015; 8(7):8348-57. PubMed ID: 26339404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying cancer-related microRNAs based on gene expression data.
    Zhao XM; Liu KQ; Zhu G; He F; Duval B; Richer JM; Huang DS; Jiang CJ; Hao JK; Chen L
    Bioinformatics; 2015 Apr; 31(8):1226-34. PubMed ID: 25505085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide analysis of multi-view data of miRNA-seq to identify miRNA biomarkers for stomach cancer.
    Pant N; Rakshit S; Paul S; Saha I
    J Biomed Inform; 2019 Sep; 97():103254. PubMed ID: 31352060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.